Emotion in slow motion: Appraisal processes in low-arousal tourism
Journal of Vacation Marketing · 2026-07 · 32 (3) · 835-849
DOI: 10.1177/13567667261448362 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Vacation Marketing, online erschienen am 13.05.2026. Verfasst von Qing Xu und 4 weiteren Autor:innen. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
While emotions are increasingly recognised as central to tourism experiences, their emergence in low-arousal contexts remains underexplored. This study explores how tourists construct emotional experiences in such settings, using a qualitative approach and semi-structured interviews. Findings reveal that emotional responses are shaped by appraisals of goal relevance, agency and responsibility attributions, and coping potential. Five positive, three negative and two mixed emotion categories emerged, influencing revisit and recommendation intentions, as well as prompting deeper reflections on tourism and everyday life. The study extends Cognitive Appraisal Theory to low-arousal contexts and highlights a managerial paradox: sustaining competitiveness requires balancing authenticity with experience enhancement.
Zitieren
APA
Xu, Q., Chia, K. W., Shuib, A. B., Sthapit, E., & Prentice, C. (2026). Emotion in slow motion: Appraisal processes in low-arousal tourism. Journal of Vacation Marketing, 32(3), 835-849. https://doi.org/10.1177/13567667261448362
Vancouver
Xu Q, Chia KW, Shuib AB, Sthapit E, Prentice C. Emotion in slow motion: Appraisal processes in low-arousal tourism. Journal of Vacation Marketing. 2026;32(3):835-849. doi:10.1177/13567667261448362
BibTeX
@article{Xu2026,
author = {Xu, Qing and Chia, Kei Wei and Shuib, Ahmad bin and Sthapit, Erose and Prentice, Catherine},
title = {Emotion in slow motion: Appraisal processes in low-arousal tourism},
journal = {Journal of Vacation Marketing},
year = {2026},
volume = {32},
number = {3},
pages = {835--849},
doi = {10.1177/13567667261448362}
}
EUVIMED